Rare diseases
Investigational molecules
Locations
Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials
SpainStudy Comparing Degarelix and Drug Combination with Radiotherapy for Patients with High-Risk Localized or Locally Advanced Prostate Cancer
SpainStudy on Ceralasertib and Durvalumab for Patients with Advanced Melanoma Resistant to PD-(L)1 Therapy
SpainStudy on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients
SpainLong-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy
SpainStudy on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors
SpainStudy on Frexalimab for Patients with Relapsing Multiple Sclerosis
SpainStudy of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation
SpainStudy on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
SpainStudy on MK-0616, Ezetimibe, and Bempedoic Acid for Adults with High Cholesterol
SpainStudy of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative
SpainStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
